Semaglutide and tirzepatide target appetite regulation, gastric emptying, and blood sugar signaling
As a result, that broader profile may contribute to both effectiveness and adverse-effect differences, but direct human receptor-selectivity comparisons are incomplete
Seek immediate emergency medical care
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Telehealth appointments may be available for eligible Florida residents
Mike and Tony Costello are the founders of Nutrivo LLC, and previous former owners of Optimum Nutrition Inc